September 23, 2025ChildrenOpen Access

Outcome of Infantile Malignant Solid Tumors: A Single-Center Experience

View Full Paper

Ask AI

Bookmark

The 5-year overall survival rate for infants with malignant solid tumors is 78.3%, indicating improved outcomes for certain tumors.
Neuroblastoma was the leading diagnosis in 30.7% of cases, with spontaneous regression noted in 29.6% of instances.
Brain tumors, especially atypical teratoid rhabdoid tumors, have significantly higher mortality rates, posing a major treatment challenge.
Intra-abdominal tumors predicted improved survival rates according to Cox regression analysis, emphasizing location-related outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Retrospective analysis shows that infantile malignant solid tumors have variable outcomes, suggesting the need for age-specific treatment strategies.

Taş et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective analysis shows that infantile malignant solid tumors have variable outcomes, suggesting the need for age-specific treatment strategies.